Trial	Phase	Sponsor	Dist.
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	<1 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
In-patient SCC TMS	N/A	University of California, Los Angeles	<1 mi
Pain and Major Depressive Disorder	N/A	University of California, Los Angeles	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
RCT of Psilocybin-assisted CBT for Depression	Phase 1/2	University of California, Los Angeles	<1 mi
Model-based Electrical Brain Stimulation	N/A	University of Southern California	<1 mi
Assessing Improvements in Mood and Sleep Trial	N/A	University of Pittsburgh	<1 mi
Regulation of Affect and Physiology in Depression	Phase 2	University of Southern California	<1 mi
Evaluating tDCS Brain-stimulation in Depression Using MRI	N/A	University of California, Los Angeles	<1 mi
Health And Response: Digital Markers for Outcomes in Perinatal Depression Treatment Study	N/A	University of California, Los Angeles	<1 mi
Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression	—	University of California, Los Angeles	<1 mi
Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements	—	Kernel	<1 mi
Characterization and Treatment of Adolescent Depression	—	National Institute of Mental Health (NIMH)	<1 mi
Improving Behavioral Health for Caregivers and Children After Pediatric Injury	N/A	Medical University of South Carolina	<1 mi
Better Sleep Study	N/A	Children's Hospital Los Angeles	<1 mi
Training Reward Responsiveness Through Virtual Reality	Phase 2	University of California, Los Angeles	<1 mi
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression	Early 1	University of California, Los Angeles	<1 mi
Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy	N/A	University of California, Los Angeles	<1 mi
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease	Phase 1/2	Children's Hospital Los Angeles	<1 mi
S.T.A.N.D. Alacrity Center Signature Project	N/A	University of California, Los Angeles	<1 mi
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis	N/A	Children's Hospital Medical Center, Cincinnati	<1 mi
RCT for Latina Mental Health Using Web-Based Apps	N/A	University of California, Los Angeles	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk	N/A	University of California, Davis	<1 mi
Cognition and Behavior With Sham Accelerated TMS	N/A	University of California, Davis	<1 mi
A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations	N/A	Stanford University	<1 mi
Biomarkers of Depression and Treatment Response	N/A	University of California, San Francisco	<1 mi
Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression	N/A	Andrew Krystal	<1 mi
CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life	—	Samphire Group, Inc.	<1 mi
Building Resilience for Surgical Recovery	N/A	The University of Texas Health Science Center, Houston	<1 mi
Closed-Loop Deep Brain Stimulation for Major Depression	N/A	Andrew Krystal	<1 mi
Reward Processing and Depressive Subtypes: Identifying Neural Biotypes	—	San Francisco Veterans Affairs Medical Center	<1 mi
Probiotic Administration for Adolescent Depression	Early 1	University of California, San Francisco	<1 mi
Treating Major Depression With Yoga Mono-therapy	N/A	University of California, San Francisco	<1 mi
Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression	N/A	San Francisco Veterans Affairs Medical Center	<1 mi
Near Infrared Spectroscopy (NIRS) for Assessment of Depression	N/A	University of California, San Francisco	<1 mi
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy	—	NeurOptics Inc	<1 mi
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project	—	University of Southern California	<1 mi
SUpport From PEeRs to Expand Access Study - Community	N/A	University of California, Berkeley	<1 mi
Psilocybin Therapy for Depression in Parkinson's Disease	Phase 2	Joshua Woolley, MD, PhD	<1 mi
Ketamine for Veterans With Parkinson's Disease	Phase 2	VA Office of Research and Development	<1 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	Phase 4	Neurocrine Biosciences	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)	Phase 2	Tonix Pharmaceuticals, Inc.	<1 mi
Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction	N/A	University of California, San Diego	<1 mi
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI	N/A	University of California, San Diego	<1 mi
Maintenance rTMS for Depression (Maitr-De)	N/A	University of California, San Diego	<1 mi
Mindfulness Engaged Neurostimulation for Depression (MEND II)	Phase 2	University of California, San Diego	<1 mi
Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches	N/A	Veterans Medical Research Foundation	<1 mi
Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study	N/A	University of California, San Diego	<1 mi
Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2)	N/A	San Diego State University	<1 mi
Sleep Health in U.S. Marines	Phase 2	San Diego State University	<1 mi
Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans	N/A	VA Office of Research and Development	<1 mi
Pramipexole to Enhance Social Connections	Phase 2	University of California, San Diego	<1 mi
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)	Phase 2/3	University of California, San Diego	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	6 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	6 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	6 mi
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness	Phase 2	Brigham and Women's Hospital	9 mi
Filipino Family Health Initiative 1.0	N/A	Kaiser Permanente	9 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	9 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	9 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	10 mi
Kintsugi Voice Device Pivotal Study	—	Kintsugi Mindful Wellness, Inc.	10 mi
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms	Phase 2	University of California, Los Angeles	11 mi
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1	—	Salma Health, Inc.	11 mi
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression	N/A	University of California, San Diego	11 mi
Nutritional Intervention for College Students With Depression	N/A	University of California, San Diego	11 mi
Meditative Neurofeedback for Depression	N/A	University of California, San Diego	11 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	14 mi
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder	Phase 2	Supernus Pharmaceuticals, Inc.	15 mi
Stratified Pharmacological Approaches for Regulating Circuit-Level Effects	Phase 2	Stanford University	16 mi
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression	Phase 2	Stanford University	16 mi
rTMS for Military TBI-related Depression	N/A	Henry M. Jackson Foundation for the Advancement of Military Medicine	16 mi
Sleep Mechanisms Of Regulating Emotions	N/A	Stanford University	16 mi
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy	Phase 2	City of Hope Medical Center	16 mi
Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and Caregivers	N/A	City of Hope Medical Center	16 mi
Optimizing Brain Excitability in Depression	N/A	Stanford University	17 mi
Sleep TMS for Depression	N/A	Stanford University	17 mi
Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans	N/A	Stanford University	17 mi
fMRI Neurofeedback With Matter Neuroscience App	N/A	Stanford University	17 mi
Biomarker-guided rTMS for Treatment Resistant Depression	Phase 3	Weill Medical College of Cornell University	17 mi
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression	N/A	Stanford University	17 mi
The Effect of Hyperoxia on Ventilation During Recovery From General Anesthesia	N/A	Stanford University	17 mi
The BEAR Program for Women With Trauma Who Have Suicidal Thoughts	N/A	Stanford University	17 mi
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings	N/A	Stanford University	17 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	20 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	20 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	21 mi
Positive Affect Treatment for Adolescents With Early Life Adversity	N/A	University of California, Irvine	22 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.